Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

類似資料

• Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a
  著者:: Quintás-Cardama, Alfonso, 等
  出版事項: (2013)
• Efficacy and safety of pegylated interferon alpha-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV): results of a phase 2 study after a 7-year median follow-up
  著者:: Masarova, Lucia, 等
  出版事項: (2017)
• Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera – single center experience
  著者:: Masarova, Lucia, 等
  出版事項: (2015)
• Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
  著者:: Masarova, Lucia, 等
  出版事項: (2017)
• The JAK kinase inhibitor CP‐690,550 supresses the growth of human polycythemia vera cells carrying the JAK2(V617F) mutation
  著者:: Manshouri, Taghi, 等
  出版事項: (2008)